The comprehensive analysis of Hamm&wittkopp Patentanwalte Partmbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm&wittkopp Patentanwalte Partmbb

Patent NumberTitleApplicantOpposition Date
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 13, 2024
EP4159204Novel Pharmaceutical CompositionNOVARTIS AGNov 11, 2024
EP4159205Novel Pharmaceutical CompositionNOVARTIS AGNov 11, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 16, 2024
EP4025188Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICA NVOct 9, 2024
EP4025187Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICA NVOct 4, 2024
EP3478286Methods Of Treating Ovarian CancerTESARO, INC.Oct 2, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 11, 2024
EP3744326Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA NVSep 5, 2024
EP3581183Tumor-Treating Pharmaceutical CompositionEISAI R&D MANAGEMENT CO., LTD.Aug 29, 2024